Cerity Partners
WST icon

Cerity Partners’s West Pharmaceutical WST Stock Holding History

Cerity Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.62M Sell
10,094
-2,198
-18% -$672K ﹤0.01% 1264
2026
Q1 		$3.08M Sell
12,292
-4,993
-29% -$1.24M ﹤0.01% 1242
2025
Q4 		$4.76M Buy
17,285
+2,993
+21% +$819K 0.01% 948
2025
Q3 		$3.75M Buy
14,292
+5,519
+63% +$1.34M 0.01% 1004
2025
Q2 		$1.92M Buy
8,773
+5,742
+189% +$1.23M ﹤0.01% 1238
2025
Q1 		$679K Sell
3,031
-2,353
-44% -$648K ﹤0.01% 1605
2024
Q4 		$1.65M Buy
5,384
+90
+2% +$28.3K ﹤0.01% 1187
2024
Q3 		$1.59M Buy
5,294
+2,566
+94% +$786K ﹤0.01% 1192
2024
Q2 		$899K Sell
2,728
-2,915
-52% -$1.03M ﹤0.01% 1274
2024
Q1 		$2.23M Buy
5,643
+3,902
+224% +$1.44M 0.01% 923
2023
Q4 		$613K Buy
1,741
+539
+45% +$191K ﹤0.01% 1187
2023
Q3 		$451K Sell
1,202
-487
-29% -$188K ﹤0.01% 1017
2023
Q2 		$646K Buy
1,689
+288
+21% +$103K ﹤0.01% 1082
2023
Q1 		$485K Sell
1,401
-373
-21% -$109K ﹤0.01% 1301
2022
Q4 		$418K Buy
1,774
+912
+106% +$216K ﹤0.01% 1021
2022
Q3 		$213K Buy
862
+111
+15% +$33.8K ﹤0.01% 1034
2022
Q2 		$227K Buy
+751
New +$244K ﹤0.01% 1030
2021
Q3 		– Sell
-709
Closed -$255K – 728
2021
Q2 		$255K Sell
709
-2
-0.3% -$661 0.01% 630
2021
Q1 		$200K Buy
+711
New +$203K ﹤0.01% 665
2019
Q2 		– Sell
-2,787
Closed -$307K – 585
2019
Q1 		$307K Buy
2,787
+288
+12% +$30K 0.02% 416
2018
Q4 		$245K Buy
2,499
+770
+45% +$83.5K 0.02% 444
2018
Q3 		$213K Buy
+1,729
New +$194K 0.01% 503

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Cerity Partners's WST Position: Q2 2026 in Review

Cerity Partners reduced its West Pharmaceutical (WST) stake by 18% in Q2 2026, selling an estimated $672K and leaving 10,094 shares worth $3.62M. The position accounts for ﹤0.01% of the portfolio, ranked #1264.

Cerity Partners first reported a position in WST in Q3 2018 and has held it in 22 quarters since. The position peaked at $4.76M in Q4 2025. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Cerity Partners held 10,094 shares of West Pharmaceutical worth $3.62M as of Q2 2026.
  • Cerity Partners sold 2,198 West Pharmaceutical shares in Q2 2026, an estimated $672K.
  • West Pharmaceutical made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #1264 holding.
  • Cerity Partners first reported a position in West Pharmaceutical in Q3 2018 and has held it in 22 quarters since.
  • Cerity Partners's West Pharmaceutical position peaked at $4.76M in Q4 2025.
  • 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.